
0.367 BATS BZX Real-Time Price As of 9:42am ET | ![]() Today’s Change | 0.31 Today|||52-Week Range 6.68 | -68.09% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 6.70, with a high estimate of 6.70 and a low estimate of 6.70. The median estimate represents a +1,725.61% increase from the last price of 0.37.
The current consensus among 1 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.